These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 30037372)
1. [Is 18F-PET-CT the First Choice for Preoperative Screening for Ia Non-small Cell Lung Cancer?]. He C; Yuan J; Chen Y; Yang L; Li L; Li T; Huang X Zhongguo Fei Ai Za Zhi; 2018 Jul; 21(7):526-529. PubMed ID: 30037372 [TBL] [Abstract][Full Text] [Related]
2. Role of 2-[18F]fluoro-2-deoxyglucose positron emission tomography in preoperative management of solid-type small-sized lung cancer. Saisho S; Yasuda K; Maeda A; Yukawa T; Okita R; Hirami Y; Shimizu K; Nakata M Ann Nucl Med; 2013 Jul; 27(6):515-22. PubMed ID: 23504519 [TBL] [Abstract][Full Text] [Related]
3. Sublobar resection is equivalent to lobectomy for clinical stage 1A lung cancer in solid nodules. Altorki NK; Yip R; Hanaoka T; Bauer T; Aye R; Kohman L; Sheppard B; Thurer R; Andaz S; Smith M; Mayfield W; Grannis F; Korst R; Pass H; Straznicka M; Flores R; Henschke CI; J Thorac Cardiovasc Surg; 2014 Feb; 147(2):754-62; Discussion 762-4. PubMed ID: 24280722 [TBL] [Abstract][Full Text] [Related]
4. False-negative rate after positron emission tomography/computer tomography scan for mediastinal staging in cI stage non-small-cell lung cancer. Gómez-Caro A; Boada M; Cabañas M; Sanchez M; Arguis P; Lomeña F; Ramirez J; Molins L Eur J Cardiothorac Surg; 2012 Jul; 42(1):93-100; discussion 100. PubMed ID: 22290911 [TBL] [Abstract][Full Text] [Related]
5. The predictive value of Mattoli MV; Massaccesi M; Castelluccia A; Scolozzi V; Mantini G; Calcagni ML Radiat Oncol; 2017 Jan; 12(1):4. PubMed ID: 28057034 [TBL] [Abstract][Full Text] [Related]
6. Clinical value of F18-fluorodeoxyglucose positron emission tomography-computed tomography in patients with non-small cell lung cancer after potentially curative surgery: experience with 241 patients. Kanzaki R; Higashiyama M; Maeda J; Okami J; Hosoki T; Hasegawa Y; Takami M; Kodama K Interact Cardiovasc Thorac Surg; 2010 Jun; 10(6):1009-14. PubMed ID: 20197344 [TBL] [Abstract][Full Text] [Related]
7. [18F]FDG PET/CT-based response assessment of stage IV non-small cell lung cancer treated with paclitaxel-carboplatin-bevacizumab with or without nitroglycerin patches. de Jong EE; van Elmpt W; Leijenaar RT; Hoekstra OS; Groen HJ; Smit EF; Boellaard R; van der Noort V; Troost EG; Lambin P; Dingemans AC Eur J Nucl Med Mol Imaging; 2017 Jan; 44(1):8-16. PubMed ID: 27600280 [TBL] [Abstract][Full Text] [Related]
8. Using positron emission tomography (PET) response criteria in solid tumours (PERCIST) 1.0 for evaluation of 2'-deoxy-2'-[18F] fluoro-D-glucose-PET/CT scans to predict survival early during treatment of locally advanced non-small cell lung cancer (NSCLC). Fledelius J; Khalil AA; Hjorthaug K; Frøkiaer J J Med Imaging Radiat Oncol; 2016 Apr; 60(2):231-8. PubMed ID: 26678718 [TBL] [Abstract][Full Text] [Related]
9. Is the prognosis of occult N2 disease similar to that of positive positron emission tomography-computed tomography (PET/CT) scan single-station N2 disease in patients with non-small cell lung cancer treated by surgical resection? Honguero Martínez AF; García Jiménez MD; García Vicente A; Genovés Crespo M; Rodríguez Ortega CR; Lázaro Sahuquillo M; Soriano Castrejón ÁM; León Atance P Rev Esp Med Nucl Imagen Mol; 2017; 36(6):350-355. PubMed ID: 28552624 [TBL] [Abstract][Full Text] [Related]
10. Does positron emission tomography scanning improve survival in patients undergoing potentially curative lung resections for non-small-cell lung cancer? Fontaine E; McShane J; Carr M; Shackcloth M; Mediratta N; Page R; Poullis M Eur J Cardiothorac Surg; 2011 Sep; 40(3):642-6. PubMed ID: 21342771 [TBL] [Abstract][Full Text] [Related]
11. Lymph node metastasis diagnosis using positron emission tomography with 2-[18F] fluoro-2-deoxy-D-glucose as a tracer and computed tomography in surgical cases of non-small cell lung cancer. Ose N; Sawabata N; Minami M; Inoue M; Shintani Y; Kadota Y; Okumura M Eur J Cardiothorac Surg; 2012 Jul; 42(1):89-92. PubMed ID: 22290887 [TBL] [Abstract][Full Text] [Related]
12. Positron emission tomography/computed tomography (PET/CT) and CT for N staging of non-small cell lung cancer. Vegar Zubović S; Kristić S; Hadžihasanović B Med Glas (Zenica); 2017 Aug; 14(2):199-203. PubMed ID: 28698537 [TBL] [Abstract][Full Text] [Related]
13. Non-small cell lung cancer: prospective comparison of integrated FDG PET/CT and CT alone for preoperative staging. Shim SS; Lee KS; Kim BT; Chung MJ; Lee EJ; Han J; Choi JY; Kwon OJ; Shim YM; Kim S Radiology; 2005 Sep; 236(3):1011-9. PubMed ID: 16014441 [TBL] [Abstract][Full Text] [Related]
14. Clinical Predictors of Nodal Metastases in Peripherally Clinical T1a N0 Non-Small Cell Lung Cancer. Ghaly G; Rahouma M; Kamel MK; Nasar A; Harrison S; Nguyen AB; Port J; Stiles BM; Altorki NK; Lee PC Ann Thorac Surg; 2017 Oct; 104(4):1153-1158. PubMed ID: 28551047 [TBL] [Abstract][Full Text] [Related]
15. Prospective Study of Serial Imaging Comparing Fluorodeoxyglucose Positron Emission Tomography (PET) and Fluorothymidine PET During Radical Chemoradiation for Non-Small Cell Lung Cancer: Reduction of Detectable Proliferation Associated With Worse Survival. Everitt S; Ball D; Hicks RJ; Callahan J; Plumridge N; Trinh J; Herschtal A; Kron T; Mac Manus M Int J Radiat Oncol Biol Phys; 2017 Nov; 99(4):947-955. PubMed ID: 29063854 [TBL] [Abstract][Full Text] [Related]
16. 18F-FAZA PET/CT in the Preoperative Evaluation of NSCLC: Comparison with 18F-FDG and Immunohistochemistry. Mapelli P; Bettinardi V; Fallanca F; Incerti E; Compierchio A; Rossetti F; Coliva A; Savi A; Doglioni C; Negri G; Gianolli L; Picchio M Curr Radiopharm; 2018; 11(1):50-57. PubMed ID: 29119942 [TBL] [Abstract][Full Text] [Related]